Effects of aminopeptidase P inhibition on kinin-mediated vasodepressor responses

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 5 45-5, 1999, Pages

  Kitamura, Shin Ichi ^a   Carbini, Luis A ^a   Simmons, William H ^b   Scicli, A Guillermo ^a  

^a HENRY FORD HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Angiotensin converting enzyme; Blood pressure; Bradykinin; Kininases

Indexed keywords

AMINOPEPTIDASE P; BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; KININASE; LISINOPRIL; STATIN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL REACTIVITY; DRUG EFFECT; ENZYME INHIBITION; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASODILATATION;

EID: 0033052548     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.5.h1664     Document Type: Article

References (39)

1. Ahmad, S., and P. E. Ward. Depressor action of bradykinin agonists relative to metabolism by angiotensin-converting enzyme, carboxypeptidase N, and aminopeptidase P. Proc. Soc. Exp. Biol. Med. 200: 115-121, 1992.
2. Bhoola, K. D., C. D. Figueroa, and K. Worthy. Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol. Rev. 44: 1-80, 1992.
3. Campbell, D. J., A. Kladis, and A. M. Duncan. Effects of converting enzyme inhibitors on angiotensin and bradykinin peptides. Hypertension 23: 439-449, 1994.
4. Carbonell, L. F., O. A. Carretero, J. M. Stewart, and A. G. Scicli. Effect of a kinin antagonist on the acute antihypertensive activity of enalaprilat in severe hypertension. Hypertension 11: 239-243, 1988.
5. Carretero, O. A., N. B. Oza, A. Piwonska, T. Ocholik, and A. G. Scicli. Measurement of urinary kallikrein activity by kinin radioimmunoassay. Biochem. Pharmacol. 25: 2265-2270, 1976.
6. Chappell, M. C., W. R. Welches, K. B. Brosnihan, and C. M. Ferrario. Inhibition of angiotensin converting enzyme by the metalloendopeptidase 3.4.24.15 inhibitor C-phenylpropyl-alanyl-alanyl-phenylalanyl-p-aminobenzoate. Peptides 13: 943-946, 1992.
7. Chen, X., S. E. Orfanos, J. W. Ryan, A. Y. Chung, D. C. Hess, and J. D. Catravas. Species variation in pulmonary endothelial aminopeptidase P activity. J. Pharmacol. Exp. Ther. 259: 1301-1307, 1991.
8. Dendorfer, A., S. Wolfrum, P. Wellhoner, K. Korsman, and P. Dominiak. Intravascular and interstitial degradation of bradykinin in isolated perfused rat heart. Br. J. Pharmacol. 122: 1179-1187, 1997.
9. Dragovic, T., R. Igic, E. G. Erdös, and S. F. Rabito. Metabolism of bradykinin by peptidases in the lung. Am. Rev. Respir. Dis. 147: 1491-1496, 1993.
10. Erdös, E. G. Some old and some new ideas on kinin metabolism. J. Cardiovasc. Pharmacol. 15, Suppl. 6: S20-S24, 1990.
11. Erdös, E. G. Inhibitors of some recently characterized kinin-metabolizing enzymes: a brief overview. Agents Actions Suppl. 38: 454-461, 1992.
12. Ersahin, C., and W. H. Simmons. Inhibition of both aminopeptidase P and angiotensin-converting enzyme prevents bradykinin degradation in the rat coronary circulation. J. Cardiovasc, Pharmacol. 30: 96-101, 1997.
13. Gavras, I., A. Manolis, and H. Gavras. Effects of ACE inhibition on the heart. J. Hum. Hypertens. 9: 455-458, 1995.
14. Genden, E. M., and C. J. Molineaux. Inhibition of endopeptidase-24.15 decreases blood pressure in normotensive rats. Hypertension 18: 360-365, 1991.
15. Griswold, J. A., C. V. Beall, C. R. Baker, Jr., D. T. Little, G. H. Little, and F. J. Behal. Bradykinin metabolism in the liver and lung of the rat. J. Surg. Res. 66: 12-20, 1996.
16. Hooper, N. M., J. Hryszko, S. Y. Oppong, and A. J. Turner. Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P. Am. J. Physiol. 236 (Heart Circ. Physiol. 5): H665-H671, 1979.
17. Ishida, H., A. G. Scicli, and O. A. Carretero. Contributions of various rat plasma peptidases to kinin hydrolysis. J. Pharmacol. Exp. Ther. 251: 817-820, 1989.
18. Ishida, H., A. G. Scicli, and O. A. Carretero. Role of angiotensin converting enzyme and other peptidases in vivo metabolism of kinins. Hypertension 14: 322-327, 1989.
19. Isono, K., J. Tamaoki, A. Chiyotani, and K. Konno. Effect of bradykinin on airway epithelial ion transport and its modulation by endogenous peptidases. Kokyu To Junkan 41: 581-585, 1993.
20. Kaplan, A. P., K. Joseph, Y. Shibayama, S. Reddigari, B. Ghebrehiwet, and M. Silverberg. The intrinsic coagulation/kinin-forming cascade: assembly in plasma and cell surfaces in inflammation. Adv. Immunol. 66: 225-272, 1997.
21. Kitamura, S., L. A. Carbini, O. A. Carretero, W. H. Simmons, and A. G. Scicli. Potentiation by aminopeptidase P of blood pressure response to bradykinin. Br. J. Pharmacol. 114: 6-7, 1995.
22. Liu, Y. H., X. P. Yang, V. G. Sharov, D. H. Sigmon, H. N. Sabbah, and O. A. Carretero. Paracrine systems in the cardioprotective effect of angiotensin-converting enzyme inhibitors on myocardial ischemia/reperfusion injury in rats. Hypertension 27: 7-13, 1996.
23. Miura, T. Adenosine and bradykinin: are they independent triggers of preconditioning? Basic Res. Cardiol. 91: 20-22, 1996.
24. Mombouli, J. V., and P. M. Vanhoutte. Kinins and endothelial control of vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol. 35: 679-705, 1995.
25. Naitoh, M., H. Suzuki, K. Arakawa, and A. Matsumoto. Role of kinin and renal ANG II blockade in acute effects of ACE inhibitors in low-renin hypertension. Am. J. Physiol. 272 (Heart Circ. Physiol. 41): H679-H687, 1997.
26. Orawski, A. T., and W. H. Simmons. Purification and properties of membrane-bound aminopeptidase P from rat lung. Biochemistry 34: 11227-11236, 1995.
27. Pesquero, J. B., G. N. Jubilut, C. J. Lindsey, and A. C. Paiva. Bradykinin metabolism pathway in the rat pulmonary circulation. J. Hypertens. 10: 1471-1478, 1992.
28. Piedimonte, G., J. A. Nadel, C. S. Long, and J. I. Hoffman. Neutral endopeptidase in the heart. Neutral endopeptidase inhibition prevents isoproterenol-induced myocardial hypoperfusion in rats by reducing bradykinin degradation. Circ. Res. 75: 770-779, 1994.
29. Prechel, M. M., A. T. Orawski, L. L. Maggiora, and W. H. Simmons. Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung. J. Pharmacol. Exp. Ther. 215: 1136-1142, 1995.
30. Remme, W. J. Bradykinin-mediated cardiovascular protective actions of ACE inhibitors. A new dimension in anti-ischaemic therapy? Drugs 4, Suppl. 5: 59-70, 1997.
31. Ryan, J. W., P. Berryer, A. Y. Chung, and D. H. Sheffy. Characterization of rat pulmonary vascular aminopeptidase P in vivo: role in the inactivation of bradykinin. J. Pharmacol. Exp. Ther. 269: 941-947, 1994.
32. Salgado, H. C., O. A. Carretero, A. G. Scicli, and R. D. Murray. Effect of DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid on the blood pressure response to vasoactive substances. J. Pharmacol. Exp. Ther. 237: 204-208, 1986.
33. Schölkens, B. A. Kinins in the cardiovascular system. Immunopharmacology 33: 209-216, 1996.
34. Sheikh, I. A., and A. P. Kaplan. Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Role of carboxypeptidase, angiotensin-converting enzyme and determination of final degradation products. Biochem. Pharmacol. 38: 993-1000, 1989.
35. Siragy, H. M. Evidence that intrarenal bradykinin plays a role in regulation of renal function. Am. J. Physiol. 265 (Endocrinol. Metab. 28): E648-E654, 1993.
36. Skidgel, R. A. Bradykinin-degrading enzymes: structure, function, distribution, and potential roles in cardiovascular pharmacology. J. Cardiovasc. Pharmacol. 20, Suppl. 9: S4-S9, 1992.
37. Ura, N., O. A. Carretero, and E. G. Erdös. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. Kidney Int. 32: 507-513, 1987.
38. Vanhoof, G., I. De Meester, M. van Sande, S. Scharpe, and A. Yaron. Distribution of proline-specific aminopeptidases in human tissues and body fluids. Eur. J. Clin. Chem. Clin. Biochem. 30: 333-338, 1992.
39. Yang, X. P., S. Saitoh, A. G. Scicli, E. Mascha, M. Orlowski, and O. A. Carretero. Effects of a metalloendopeptidase-24.15 inhibitor on renal hemodynamics and function in rats. Hypertension 23, Suppl. I: I-235-I-239, 1994.